<DOC>
	<DOC>NCT02699671</DOC>
	<brief_summary>The purpose of this study is to evaluate the relative effectiveness and safety of Bioresorbable Vascular Scaffold in acute myocardial infarction compared to other (drug eluting stents) DES.</brief_summary>
	<brief_title>IRIS-BVS AMI Registry</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Age 19 and more Acute myocardial infarction Intervention with Bioresorbable Vascular Scaffold Agreed with written informed consent form Bypass graft surgery (CABG) recommended Lesion with previous bypass graft surgery (CABG) Severe calcification and/or severe tortuosity Contraindication to antiplatelet agent or Inability to take dual antiplatelet therapy within 1 year Life expectancy of 1year and under Subjects scheduled to receive cardiac surgery or serious noncardiac surgery Cardiac shock</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Bioresorbable Vascular Scaffold</keyword>
	<keyword>Routine Clinical Practice</keyword>
	<keyword>Angioplasty, Transluminal, Percutaneous Coronary</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>drug eluting stent</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>